Showing results (221-230 of 379) with videos related to
Sort By:
Pageof 38
European Journal of Pharmacology|August 8, 1980
Inhibition of murine embryonic development by alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylaseJ R Fozard, M L Part, N J Prakash, et al.The Biochemical Journal|May 15, 1981
Indirect evidence for a strict negative control of S-adenosyl-L-methionine decarboxylase by spermidine in rat hepatoma cellsP S Mamont, A M Joder-Ohlenbusch, M Nussli, et al.Journal of Sports Sciences|May 10, 2012
The effects of warm-up on intermittent sprint performance in a hot and humid environmentPongson Yaicharoen, Karen Wallman, Alan Morton, et al.Hepatology (Baltimore, Md.)|July 1, 1997
Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitisJ Grove, A K Daly, M F Bassendine, et al.Plant Physiology|July 1, 1995
Characterization of a C-5,13-Cleaving Enzyme of 13(S)-Hydroperoxide of Linolenic Acid by Soybean SeedY. P. Salch, M. J. Grove, H. Takamura, et al.Birth Defects Original Article Series|January 1, 1974
Inheritance of idiopathic nephrotic syndromeP I Bader, J Grove, W E Nance, et al.International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
A phase I study of the combination of benznidazole and CCNU in manJ T Roberts, N M Bleehen, F Y Lee, et al.Journal of the National Cancer Institute|November 24, 1999
DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90L R Kelland, S Y Sharp, P M Rogers, et al.British Journal of Cancer|September 29, 2004
Characterisation of molecular events following cisplatin treatment of two curable ovarian cancer models: contrasting role for p53 induction and apoptosis in vivoP A Clarke, K E Pestell, F Di Stefano, et al.Clinical Pharmacology and Therapeutics|January 20, 2009
From darkness to light with biomarkers in early clinical trials of cancer drugsC P Carden, U Banerji, S B Kaye, et al.Pageof 38